Zur Rose Group AG Stock
Price
Target price
€7.71
€7.71
2.530%
0.19
2.530%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Zur Rose Group
sharewise wants to provide you with the best news and tools for Zur Rose Group, so we directly link to the best financial data sources.
Financials
News
DocMorris publishes invitation to the Annual General Meeting
DocMorris publishes invitation to the Annual General Meeting
DocMorris achieves strong revenue growth in Q1 2026 – on track for EBITDA break-even
DocMorris achieves strong revenue growth in Q1 2026 – on track for EBITDA break-even
DocMorris and Google partner to advance one of Europe’s leading AI-powered digital health platform
DocMorris and Google partner to advance one of Europe’s leading AI-powered digital health platform
DocMorris achieves 2025 targets – focus on profitability, growth and expansion of digital health platform
DocMorris achieves 2025 targets – focus on profitability, growth and expansion of digital health platform
DocMorris AG announces changes to its Board of Directors
DocMorris AG announces changes to its Board of Directors
DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter
DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2026
DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2026